Your selections:
The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer
- Biswas, Tithi, Efird, Jimmy T., Prasad, Shreya, Jindal, Charulata, Walker, Paul R.
Local therapy for triple-negative breast cancer: a comprehensive review
- Grubb, William, Young, Rebekah, Efird, Jimmy, Jindal, Charulata, Biswas, Tithi
Tumor-infiltrating lymphocytes and prognosis: a poled individual patient analysis of early-stage triple-negative breast cancers
- Loi, Sherene, Drubay, Damien, Gray, Robert, Munzone, Elisabetta, Lemonnier, Jerome, Sotiriou, Christos, Piccart, Martine, Kellokumpu-Lehtinen, Pirkko-Liisa, Vingiani, Andrea, Gray, Kathryn, Andre, Fabrice, Denkert, Carsten, Adams, Sylvia, Salgado, Roberto, Michiels, Stefan, Pruneri, Giancarlo, Francis, Prudence, Lacroix-Triki, Magali, Joensuu, Heikki, Dieci, Maria Vittoria, Badve, Sunil, Demaria, Sandra
MiRNAs and other epigenetic changes as biomarkers in triple negative breast cancer
- Mathe, Andrea, Scott, Rodney J., Avery-Kiejda, Kelly A.
Copy number variation in triple negative breast cancer samples associated with lymph node metastasis
- Pariyar, Mamta, Johns, Andrea, Thorne, Rick F., Scott, Rodney J., Avery-Kiejda, Kelly A.
Gene expression, copy number variation and DNA methylation associated with disease outcome in triple negative breast cancer
Are you sure you would like to clear your session, including search history and login status?